![Stefan Rehnmark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Rehnmark
Directeur Technique/Scientifique/R&D chez
GABATHER AB
Profil
Stefan Rehnmark is the founder of Axcentua Pharmaceuticals AB, which was founded in 2007.
He held the title of Chief Executive & Scientific Officer at the company.
Dr. Rehnmark is also the founder of Noviga Research AB. Dr. Rehnmark's current job(s) include being a Director at LIDDS AB since 2024 and serving as the Chief Scientific Officer at Gabather AB. Dr. Rehnmark's former job was as an Assistant Professor at the University of Stockholm from 1994 to 2000.
Dr. Rehnmark obtained a doctorate degree from the University of Stockholm.
Postes actifs de Stefan Rehnmark
| Sociétés | Poste | Début |
|---|---|---|
| GABATHER AB | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| LIDDS AB | Directeur/Membre du Conseil | 27/05/2024 |
Anciens postes connus de Stefan Rehnmark
| Sociétés | Poste | Fin |
|---|---|---|
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1998 |
Noviga Research AB | Fondateur | - |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs for pancreatic cancer | Directeur Général | - |
Formation de Stefan Rehnmark
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs for pancreatic cancer | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Gabather AB
 Gabather AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops mental health drugs | Health Technology |
Noviga Research AB |
